Quest Laboratories Limited (NSE:QUESTLAB)
93.50
+0.90 (0.97%)
Oct 7, 2026, 3:18 PM IST
Quest Laboratories Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 1.05 | 1.13 | 1.44 | 1.2 | 15.69 |
Short-Term Investments | 106.47 | 475.14 | 66.68 | - | - |
Trading Asset Securities | 15.34 | 17.12 | 0.88 | - | - |
Cash & Short-Term Investments | 122.86 | 493.38 | 69 | 1.2 | 15.69 |
Cash Growth | -75.10% | 615.04% | 5638.18% | -92.34% | 1465.22% |
Accounts Receivable | 362.14 | 300.32 | 244.43 | 199.38 | 220.62 |
Other Receivables | 10.37 | 7.19 | 0.01 | 20.22 | 15.73 |
Receivables | 372.51 | 307.59 | 245.23 | 220.95 | 237.03 |
Inventory | 386.2 | 213.68 | 161.23 | 111.57 | 10.87 |
Prepaid Expenses | 0.27 | 0.14 | 0.11 | 0.2 | 0.2 |
Other Current Assets | 43.95 | 55.28 | 27.42 | 5.84 | 4.61 |
Total Current Assets | 925.79 | 1,070 | 502.98 | 339.77 | 268.4 |
Property, Plant & Equipment | 162.74 | 118.72 | 102.39 | 98.39 | 73.76 |
Long-Term Investments | 33.34 | 29.16 | - | 0.88 | 0.88 |
Other Long-Term Assets | 0 | - | - | 29.58 | 4.95 |
Total Assets | 1,122 | 1,218 | 605.38 | 469.42 | 347.99 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 56.09 | 57.3 | 206.26 | 246.02 | 170.47 |
Accrued Expenses | 7.04 | 21.01 | 9.44 | 6.61 | 12.84 |
Short-Term Debt | 65.34 | 284.84 | 38.52 | 22.21 | - |
Current Portion of Long-Term Debt | 4.42 | 4.17 | 3.34 | - | 17.91 |
Current Income Taxes Payable | - | 2.82 | 33.75 | 17.92 | 13.18 |
Other Current Liabilities | 2.65 | 1.64 | 10.75 | 0.71 | 15.05 |
Total Current Liabilities | 135.53 | 371.77 | 302.05 | 293.46 | 229.45 |
Long-Term Debt | 9.09 | 13.57 | 8.99 | 18.76 | 13.35 |
Pension & Post-Retirement Benefits | - | - | - | - | 0.67 |
Long-Term Deferred Tax Liabilities | 9.02 | 13.11 | 7.65 | 6.2 | 4.59 |
Other Long-Term Liabilities | 0 | - | -0 | - | - |
Total Liabilities | 153.65 | 398.45 | 318.69 | 318.42 | 248.05 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 163.87 | 163.87 | 119.38 | 10.79 | 10.79 |
Additional Paid-In Capital | - | 374.21 | 23 | 15.98 | 15.98 |
Retained Earnings | - | 281.43 | 144.31 | 124.23 | 73.17 |
Comprehensive Income & Other | 804.35 | - | - | - | - |
Shareholders' Equity | 968.22 | 819.51 | 286.68 | 150.99 | 99.94 |
Total Liabilities & Equity | 1,122 | 1,218 | 605.38 | 469.42 | 347.99 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 78.85 | 302.58 | 50.85 | 40.97 | 31.25 |
Net Cash (Debt) | 44.01 | 190.8 | 18.15 | -39.77 | -15.56 |
Net Cash Growth | -76.94% | 951.15% | - | - | - |
Net Cash Per Share | 2.69 | 11.64 | 1.11 | -3.69 | -1.44 |
Filing Date Shares Outstanding | 16.39 | 16.39 | 11.94 | 10.79 | 10.79 |
Total Common Shares Outstanding | 16.39 | 16.39 | 11.94 | 10.79 | 10.79 |
Working Capital | 790.25 | 698.31 | 200.93 | 46.31 | 38.96 |
Book Value Per Share | 59.08 | 50.01 | 24.01 | 14.00 | 9.26 |
Tangible Book Value | 968.22 | 819.51 | 286.68 | 150.99 | 99.94 |
Tangible Book Value Per Share | 59.08 | 50.01 | 24.01 | 14.00 | 9.26 |
Land | 39.39 | 7.27 | 1.04 | 1.04 | 1.04 |
Buildings | 73.47 | 73.11 | 73.36 | 68.19 | 53.11 |
Machinery | 86.37 | 81.18 | 65.62 | 61.39 | 46.34 |
Construction In Progress | 14.6 | - | - | - | - |